CE mark
The device received the CE mark and has been registered with the “Repertorio dei Dispositivi Medici del Ministero della Salute Italiano”. The date of publication is September 24, … Continue reading
All posts by: swiss
Shahar Tsabari, M.D., presenting at the Swiss-Korean Life Science Symposium in Seoul
Seoul, South-Korea (October 23, 2015) Invited by the State Secretary for Education, Research and Innovation, Swiss Medendi is participating in the 2nd Swiss-Korean Life Science Symposium from October 21 to 23, 2015. Shahar Tsabari is presenting Swiss Medendi within the MedTech Start-up Pitching on Friday, October 23, in the JW Marriott Dongdaemoon in Seoul, Korea. … Continue reading
Patent granted for Japan
Tokyo, Japan (October 5, 2015) Swiss Medendi’s patent has been granted by the Japan Patent Office. The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens the protection of Swiss Medendi’s intellectual property in Japan … Continue reading
Patents granted for Eurasia
Moscow, Russia (October 5, 2015) Swiss Medendi’s patent, has been granted by the Eurasian Patent Organization (EAPO). The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens the protection of Swiss Medendi’s intellectual property in … Continue reading
Patent granted for China
Beijing, China (July 26, 2015) Swiss Medendi’s patent,has been granted by the State Intellectual Property Office (SIPO) of the People’s Republic of China. The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens the protection … Continue reading
Patent granted for Mexico
Mexico City, Mexico (June 16, 2015) Swiss Medendi’s patent, has been granted by the Mexican Patent Office, the Instituto Mexicano de la Propiedad Industrial (IMPI). The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens … Continue reading
Swiss Medendi among the finalists in the StartCup Ticino
Lugano, Switzerland (December 04, 2014) Swiss Medendi succeeded in the semi-final of StartCup Ticino and was selected to participate in the StartCup Ticino final, competing against four other ventures for the Ticino StartCup 2014. About StartCup Ticino The StartCup Ticino competition is an initiative of the USI-SUPSI Start-Up Promotion Center (CP Start-Up) aiming at fostering … Continue reading
Winner of the W. A. de Vigier Award
Solothurn, Switzerland (June 14, 2014) Among more than 250 Swiss start-up companies, Swiss Medendi has won the prestigious W. A. de Vigier Award – endowed with CHF 100’000. The president of the W. A. de Vigier Foundation, Dr. Daniel Borer, highlighted Swiss Medendi as his personal favorite – not only because of his medical background … Continue reading
Shahar Tsabari, M.D., presenting at CTI Invest
Zurich, Switzerland (March 11, 2014) Shahar Tsabari, M.D., presents Swiss Medendi at CTI Invest on the Swiss Venture Day 2014. The Swiss Venture Day takes place in the SIX Swiss Exchange in Zurich, Switzerland. About CTI Invest CTI Invest is a private non-profit organization focused on the promotion of the Swiss venture landscape. Since its … Continue reading
Patent granted for Europe
EPO (December 18, 2013) Swiss Medendi’s patent, has been granted by the the European Patent Office (EPO). The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. About Swiss Medendi Swiss Medendi SA is a Switzerland based start-up … Continue reading
- 1
- 2